U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07901738) titled 'Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children' on Oct. 21.
Brief Summary: Recurrent respiratory papillomatosis (RRP) is a rare disease in which wart-like growths caused by human papillomavirus (HPV) types 6 or 11 form in the airway. These growths can affect the voice and breathing and often come back after they are removed, meaning many children will need repeated surgeries to keep their airway open. There is no medicine approved to treat RRP in children.
This study is testing zopapogene imadenovec, an investigational immunotherapy designed to help the immune system recognize and contro...